Seoul National University Hospital
Seoul, 110-744, South Korea
Location status: Recruiting
NCT Number: NCT01670383
The objective of this study is to find a new therapeutic strategy by investigating the serial serum samples of patients with sepsis or postresuscitation state.
Interested in participating?
Request Info16 year and older
All sexes
Observational
Seoul, 110-744, South Korea
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month
All cause mortality within 1-month
Time frame: until hospital discharge, an expected average of 2 weeks
All cause mortality during hospitalization
Time frame: Until ward transfer or discharge, an expected average of 7 days
Time frame: at discharge, an expected average of 2 weeks and at 6-month
Favorable neurologic outcome is used for outcome measure in postresuscitation patients only.
Favorable neurologic outcome means cerebral performance category 1 and 2. This outcome is measured at discharge and 6-month after admission.
Interested in participating?
Request InfoSeoul National University Hospital
Other
Repository for Samples Collected From Sepsis and Postresuscitation Patients in Emergency Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05604430
Altered Mental Status, Cardiac Arrest
Baton Rouge, Louisiana, United States
View Trial DetailsNCT07242027
Cardiac Arrest, Cardiovascular Diseases
Zabrze, Silesian Voivodeship, Poland
View Trial DetailsNCT05893420
COVID-19, Cardiac Arrest
New Haven, Connecticut, United States
View Trial DetailsNCT04974775
COVID-19, Cardiac Arrest
Helsingborg, Sweden
View Trial Details